Translational Epigenetics

Aim & scope

Translational Epigenetics is a major new series of print and ebooks in biomedical research reference literature. The series reviews advances in epigenetics and epigenomics, with an emphasis on clinical opportunity.

The area of Translational Epigenetics deserves special consideration in what is otherwise a component of biological science because the origins of health and susceptibility to disease may in part be attributed to “epigenesis,” the differentiation programs that orchestrate when and where genes and their products are expressed within the genetic blueprint.

Many varied and complex molecular processes contribute to these programs, with products including transcription factors, chromatin regulators, DNA methylation, histone modifications, and RNAs. Epigenetic mechanisms that control stem cell differentiation and organogenesis may also contribute to the biological response to endogenous and exogenous forms of stimuli that result in disease.

Written and edited by leading researchers, the series is primarily intended for researchers in genomics, epigenetics, and related biomedical disciplines at the graduate level and above.

Audience

Primary Market/Audience:

Active researchers in genomics, epigenetics, molecular biology, cell biology, and developmental biology
Clinician scientists exploring translational applications of epigenetics in clinical settings

Secondary Market/Audience:

Graduate and postgraduate students in genomics, epigenetics, and related biomedical fields
Educators and academic faculty
Healthcare professionals interested in epigenetic diagnostics and therapies
Pharmaceutical and biotechnology industry professionals involved in drug discovery and development
Public health researchers focusing on disease susceptibility and prevention

Publish a book with Elsevier

Series Editor

Trygve Tollefsbol

Distinguished Professor of Biology and Senior Scientist

University of Alabama at Birmingham